Aardvark’s lead candidate ARD-101 is being investigated in a Phase III study for hyperphagia in Prader-Willi syndrome.

Türkiye High Level Strategic Cooperation Council in a joint declaration after its 7th session on Thursday pledged to further ...

Acarix, a leader in rapid AI and acoustics-based cardiac diagnostics, today reported its 2024 year-end financial results. "The company continues ...